Journal of
Clinical Medicine
Correction
Correction: Kim, Young-Gun; Jeon, Ja Young; Kim, Hae Jin; Kim, Dae Jung; Lee, Kwan-Woo; Moon,
So Young; Han, Seung Jin. Risk of Dementia in Older Patients with Type 2 Diabetes on
Dipeptidyl-Peptidase IV Inhibitors versus
Sulfonylureas: A Real-World Population-Based
Cohort Study. Journal of Clinical Medicine 2019, 8, 28
Young-Gun Kim1,2 , Ja Young Jeon3, Hae Jin Kim3, Dae Jung Kim3 , Kwan-Woo Lee3, So Young Moon4and Seung Jin Han3,*
1 Department of Medical Sciences, Ajou University Graduate School, Suwon 16499, Korea;
2 Ministry of Health and Welfare, Gyeonggi Provincial Government, Suwon 16444, Korea
3 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Korea;
[email protected] (J.Y.J.); [email protected] (H.J.K.); [email protected] (D.J.K.);
[email protected] (K.-W.L.)
4 Department of Neurology, Ajou University School of Medicine, Suwon 16499, Korea; [email protected]
* Correspondence: [email protected]; Tel.: +82-31-219-5126; Fax: +82-31-219-4497
Received: 20 March 2019; Accepted: 20 March 2019; Published: 20 March 2019
The authors wish to make the following corrections to this paper [1].
In Figure1, all “SGLT-2i” should be replaced by “SU”. Correspondingly, in the figure legend, the definition of “SGLT-2i” should be removed.
After correction, Figure1should be displayed as below:
J. Clin. Med. 2019, 8, x; doi: FOR PEER REVIEW www.mdpi.com/journal/jcm
Correction
Correction: Kim, Young-Gun; Jeon, Ja Young;
Kim, Hae Jin; Kim, Dae Jung; Lee, Kwan-Woo;
Moon, So Young; Han, Seung Jin. Risk of Dementia in Older Patients with Type 2 Diabetes on
Dipeptidyl-Peptidase IV Inhibitors Versus
Sulfonylureas: A Real-World Population-Based
Cohort Study. Journal of Clinical Medicine 2019, 8, 28
Young-Gun Kim 1,2, Ja Young Jeon 3, Hae Jin Kim 3, Dae Jung Kim 3, Kwan-Woo Lee 3, So Young Moon 4 and Seung Jin Han 3,*
1 Department of Medical Sciences, Ajou University Graduate School, Suwon 16499, Republic of Korea;
2 Ministry of Health and Welfare, Gyeonggi Provincial Government, Suwon 16444, Republic of Korea
3 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Republic of Korea; [email protected] (J.Y.J.); [email protected] (H.J.K.); [email protected] (D.J.K.);
[email protected] (K.-W.L.)
4 Department of Neurology, Ajou University School of Medicine, Suwon 16499, Republic of Korea;
* Correspondence: [email protected]; Tel.: +82-31-219-5126; Fax: +82-31-219-4497 Received: date; Accepted: date; Published: date
The authors wish to make the following corrections to this paper [1].
In Figure 1, all “SGLT-2i” should be replaced by “SU”. Correspondingly, in the figure legend, the definition of “SGLT-2i” should be removed.
After correction, Figure 1 should be displayed as below:
Figure 1. Flow chart of the sample selection process. DM, diabetes mellitus; DPP-4i, dipeptidyl-peptidase IV inhibitor; N, number; SU, sulfonylurea.
Figure 1.Flow chart of the sample selection process. DM, diabetes mellitus; DPP-4i, dipeptidyl-peptidase IV inhibitor; N, number; SU, sulfonylurea.
J. Clin. Med.2019,8, 389; doi:10.3390/jcm8030389 www.mdpi.com/journal/jcm
J. Clin. Med.2019,8, 389 2 of 2
The authors would like to apologize for any inconvenience caused to the readers by these changes.
Reference
1. Kim, Y.G.; Jeon, J.; Kim, H.; Kim, D.; Lee, K.W.; Moon, S.; Han, S. Risk of dementia in older patients with type 2 diabetes on dipeptidyl-peptidase IV inhibitors versus sulfonylureas: A real-world population-based cohort study.J. Clin. Med.2019,8, 28. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).